With 0.14 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.99 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $11.8 whereas the lowest price it dropped to was $10.45. The 52-week range on MOVE shows that it touched its highest point at $69.68 and its lowest point at $4.67 during that stretch. It currently has a 1-year price target of $300.00. Beta for the stock currently stands at 0.63.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MOVE was up-trending over the past week, with a rise of 5.77%, but this was up by 57.40% over a month. Three-month performance surged to 72.28% while six-month performance rose 100.68%. The stock lost -80.30% in the past year, while it has lost -69.07% so far this year.
Float and Shares Shorts:
At present, 0.83 million MOVE shares are outstanding with a float of 0.68 million shares on hand for trading. On 2025-11-14, short shares totaled 0.13 million, which was 1598.9999999999998 higher than short shares on 1760486400. In addition to Dr. John Mastrototaro Ph.D. as the firm’s CEO, President & Director, Mr. Michael Aaron Leabman serves as its Founder, CTO & Director.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-09-30, MOVE reported revenue of $80000.0 and operating income of -$2591000.0. The EBITDA in the recently reported quarter was -$2489000.0 and diluted EPS was -$4.73.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With MOVE analysts setting a high price target of 300.0 and a low target of 300.0, the average target price over the next 12 months is 300.0. Based on these targets, MOVE could surge 2719.55% to reach the target high and rise by 2719.55% to reach the target low. Reaching the average price target will result in a growth of 2719.55% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$42.9 being high and -$42.9 being low. For MOVE, this leads to a yearly average estimate of -$42.9. The surprise factor in the prior quarter was -$7.2. Based on analyst estimates, the high estimate for the next quarter is -$3.6 and the low estimate is -$3.6. The average estimate for the next quarter is thus -$3.6.
